|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 |
| (11) | Number of the document | 2504435 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10785571.0 |
| Date of filing the European patent application | 2010-11-25 | |
| (97) | Date of publication of the European application | 2012-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/058123 |
| Date | 2010-11-25 |
| (87) | Number | WO 2011/066475 |
| Date | 2011-06-03 |
| (30) | Number | Date | Country code |
| 264668 P | 2009-11-26 | US | |
| 295721 P | 2010-01-17 | US | |
| 372072 P | 2010-08-09 | US |
| (72) |
AVKIN-NACHUM, Sharon, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
7999 Gateway Boulevard, Suite 310, Newark, CA 94560,
US
|
| (54) | SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS |
| SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS |